Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002438 · ClinicalTrials.gov registry record · NA
A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients
A NA study of HIV Infections and Histoplasmosis, sponsored by Janssen.
- Completed
- Registry status
- NA
- Development phase
- 7
- Study locations
NCT00002438 is a NA study of HIV Infections and Histoplasmosis that has completed, run by Janssen. The trial reports 7 study locations across 3 states.
The verdict
NCT00002438, a NA study of HIV Infections and Histoplasmosis, has completed, sponsored by Janssen.
- COMPLETED
- Registry status
- NA
- Development phase
- 7
- Study locations
Study Summary
To assess the safety and efficacy of itraconazole versus placebo for prevention of histoplasmosis in HIV-infected patients with CD4 counts \< 150 cells/mm3 who reside where histoplasmosis is endemic. To assess the safety and efficacy of itraconazole for preventing other debilitating fungal infections, such as cryptococcosis, aspergillosis, recalcitrant oropharyngeal or vaginal candidiasis, and recurrent esophageal candidiasis.
Conditions Studied
Interventions
- DRUG Itraconazole
Study Locations (7)
Tennessee
- ASCC - Memphis
- Dr Michael Threikeld - Memphis
- Dr Mark A Pierce - Nashville
Indiana
- Infectious Diseases Research Clinic / Indiana Univ Hosp - Indianapolis
- Infectious Diseases of Indianapolis - Indianapolis
Missouri
- Univ of Missouri at Kansas City School of Medicine - Kansas City
- Infectious Diseases Association / Research Med Ctr - Kansas City
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002438
The ClinicalTrials.gov registry entry for NCT00002438 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Janssen, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Itraconazole is the first listed.
NCT00002438 reports 7 study locations spanning 3 distinct geographic areas - top geographies include Tennessee, Indiana, Missouri.
Frequently Asked Questions
What is clinical trial NCT00002438 about?
NCT00002438 is a clinical study titled "A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients". To assess the safety and efficacy of itraconazole versus placebo for prevention of histoplasmosis in HIV-infected patients with CD4 counts \< 150 cells/mm3 who reside where histoplasmosis is endemic. To assess the safety and efficacy of itraconazole for preventing other debilitating fungal infection...
What is the current status of trial NCT00002438?
This trial is currently completed. It is a NA study.
What conditions does trial NCT00002438 study?
This clinical trial studies the following conditions: HIV Infections, Histoplasmosis.
What interventions are being tested in trial NCT00002438?
The interventions under investigation include: Itraconazole (DRUG).
Who is sponsoring clinical trial NCT00002438?
This trial is sponsored by Janssen, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002438 being conducted?
This trial has 7 study locations across Indiana, Missouri, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.